MeDucation· @MeDucationai · X·· 4 天前评分45
正文 · 原文
@lungoncdoc is raising the question lung oncologists need before Madrid: if resistance lives in the TOP1 payload, a new antibody target may not rescue response, and most of the lung ADCs in play carry TOP1 payloads. #ESMO26 #LCSM
39 浏览 · 0 赞 · 0 转发 · 0 回复
Important implications for lung cancer, too. We’re behind breast cancer in understanding optimal ADC sequencing, but emerging data raise an important concern: switching targets may not overcome resistance when the payload remains the same... #ESMO26在 X 查看被引用的帖子
来源:MeDucation · x.com
